300511 Stock Overview
Engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Shanghai Xuerong Biotechnology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.83 |
52 Week High | CN¥5.90 |
52 Week Low | CN¥2.40 |
Beta | 0.22 |
11 Month Change | -1.29% |
3 Month Change | 37.28% |
1 Year Change | -34.42% |
33 Year Change | -47.25% |
5 Year Change | -37.93% |
Change since IPO | -77.10% |
Recent News & Updates
Recent updates
Shareholder Returns
300511 | CN Food | CN Market | |
---|---|---|---|
7D | -5.0% | -3.5% | -2.1% |
1Y | -34.4% | -6.7% | 2.8% |
Return vs Industry: 300511 underperformed the CN Food industry which returned -2.7% over the past year.
Return vs Market: 300511 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
300511 volatility | |
---|---|
300511 Average Weekly Movement | 10.2% |
Food Industry Average Movement | 6.9% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300511 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300511's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 2,513 | Yongping Yang | www.xuerong.com |
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China. It offers shiitake, shiji, king oyster, velvet, antler, and shiitake mushrooms, as well as Pleurotus eryngii and Flammulina velutipes. The company was formerly known as Shanghai Gaorong Food Co., Ltd.
Shanghai Xuerong Biotechnology Co.,Ltd. Fundamentals Summary
300511 fundamental statistics | |
---|---|
Market cap | CN¥1.91b |
Earnings (TTM) | -CN¥223.86m |
Revenue (TTM) | CN¥2.26b |
0.8x
P/S Ratio-8.5x
P/E RatioIs 300511 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300511 income statement (TTM) | |
---|---|
Revenue | CN¥2.26b |
Cost of Revenue | CN¥2.28b |
Gross Profit | -CN¥14.73m |
Other Expenses | CN¥209.12m |
Earnings | -CN¥223.86m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.45 |
Gross Margin | -0.65% |
Net Profit Margin | -9.89% |
Debt/Equity Ratio | 180.9% |
How did 300511 perform over the long term?
See historical performance and comparison